Skip to main content
. Author manuscript; available in PMC: 2015 May 28.
Published in final edited form as: Transplantation. 2012 Jul 27;94(2):139–144. doi: 10.1097/TP.0b013e318254757d

Table 3.

Distribution of time from nephrectomy to cancer diagnosis among the living kidney donor sample

Cancer Type Median
(years)
Range
(years)
Full Donor Sample

Skin 4.8 0.1–18.2
Total Non-skin 9.2 0.6–19.0

Cancers By Type, Full Donor Sample

Melanoma 3.6 0.7–13.2
Colon 11.6 10.1–13.0
Lung 12.5 4.8–18.4
Kidney 7.7 4.9–10.5
Lymphoma 11.5 8.0–15.7
Leukemia 6.4 3.0–9.8
Myeloma 8.4 8.4
Central nervous system 11.2 6.0–13.8
Endocrine 8.7 1.9–17.9
Bone 10.9 10.8–10.9
Mouth 14.5 14.5
Other 6.2 0.6–12.5

Male-Specific Cancers

Prostate 9.1 4.6–19.0
Testes 2.6 2.6

Female-Specific Cancers

Breast 8.6 3.2–16.5
Ovary 8.4 1.4–11.6
Uterus 5.2 0.8–7.1